HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy.

AbstractAIM:
  Operative ligation of the portosystemic shunt may control hepatic encephalopathy effectively, but the subsequent increase in portal vein pressure (PVP) leads to high mortality. Splenectomy can decrease inflow into the portal system, resulting in decreased portal pressure.
METHODS:
  We retrospectively examined the effect of splenectomy in combination with shunt closure on portosystemic encephalopathy.
RESULTS:
  Clinical symptoms of encephalopathy disappeared in all six patients who underwent splenectomy in combination with portosystemic shunt ligation, with the exception of one patient who had relapsing encephalopathy after 6 months. Follow-up computed tomography showed complete obliteration of the portosystemic shunts, except in the one patient with relapsing encephalopathy who underwent balloon-occluded retrograde transvenous obliteration for the remaining splenorenal shunt 8 months after surgery. PVP significantly decreased after splenectomy. PVP did not increase to the baseline PVP value after ligation of the shunts, except in two patients who had elevated PVP after surgery: PVP increased from 18 to 19 mmHg after ligation in one patient and from 18 to 23 mmHg in one patient.
CONCLUSION:
Splenectomy followed by surgical ligation of the portosystemic shunt may be feasible and safe for cirrhotic patients with portosystemic shunts.
AuthorsHirotaka Tashiro, Kentaro Ide, Hironobu Amano, Tsuyoshi Kobayashi, Takashi Onoe, Kohei Ishiyama, Shintaro Kuroda, Hirofumi Tazawa, Hirotaka Kono, Hiroshi Aikata, Shoichi Takahashi, Kazuaki Chayama, Hideki Ohdan
JournalHepatology research : the official journal of the Japan Society of Hepatology (Hepatol Res) Vol. 43 Issue 3 Pg. 249-54 (Mar 2013) ISSN: 1386-6346 [Print] Netherlands
PMID22734925 (Publication Type: Journal Article)
Copyright© 2012 The Japan Society of Hepatology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: